SEC Form 4 · accession 0001844320-26-000009
Oscar Health, Inc. · OSCR
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mario Schlosser
Director
Period of report
Jun 2, 2026
Accepted (ET)
Jun 4, 2026 · 4:16 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001568651
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1,F2,F3 | Jun 2, 2026 | S | 24,452 | $21.74 | D | 490,534 | D | |
| Class A Common StockF1,F4,F3 | Jun 2, 2026 | S | 9,668 | $22.45 | D | 480,866 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025 to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.03 to $22.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
- F3Includes shares to be issued in connection with the vesting of one or more restricted stock units.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $22.03 to $22.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.